ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
29.60
+3.21 (12.16%)
At close: Oct 8, 2025, 4:00 PM EDT
29.72
+0.12 (0.41%)
Pre-market: Oct 9, 2025, 4:39 AM EDT
ClearPoint Neuro Market Cap
ClearPoint Neuro has a market cap or net worth of $841.45 million as of October 8, 2025. Its market cap has increased by 164.44% in one year.
Market Cap
841.45M
Enterprise Value
835.37M
1-Year Change
164.44%
Ranking
Category
Stock Price
$29.60
Market Cap Chart
Since May 22, 2012, ClearPoint Neuro's market cap has increased from $30.30M to $841.45M, an increase of 2,677.07%. That is a compound annual growth rate of 28.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 841.50M | 98.33% |
| Dec 31, 2024 | 424.30M | 153.77% |
| Dec 29, 2023 | 167.20M | -19.62% |
| Dec 30, 2022 | 208.00M | -21.57% |
| Dec 31, 2021 | 265.20M | -1.08% |
| Dec 31, 2020 | 268.10M | 267.26% |
| Dec 31, 2019 | 73.00M | 337.13% |
| Dec 31, 2018 | 16.70M | -41.61% |
| Dec 29, 2017 | 28.60M | 132.52% |
| Dec 30, 2016 | 12.30M | -56.84% |
| Dec 31, 2015 | 28.50M | -41.84% |
| Dec 31, 2014 | 49.00M | -42.22% |
| Dec 31, 2013 | 84.80M | 10.42% |
| Dec 31, 2012 | 76.80M | 153.47% |
| May 22, 2012 | 30.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 760.60B |
| Johnson & Johnson | 453.25B |
| AbbVie | 403.56B |
| UnitedHealth Group | 325.45B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 232.89B |